Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS30003813
Proximate region of VIS (GRCh38)
VIS
Enhancer
Enhancer/Promoter
Promoter
Gene
26221583
26124145
26139116
26158146
26171349
26160765
26172802
26114873
26123926
26120087
26127861
26154989
26160742
26164617
26166557
26163400
26164488
26152370
26153269
26128000
26128827
26118590
26119383
26156354
26157107
26161001
26161200
26161401
26161600
26141513
26141662
26168228
Basic Information
VIS ID
TVIS30003813
Fusion event
HIV-HIST1H2BD integration
Validated
No
Detection method
QiaQuick PCR and Sequencing
Data source
download(RID)
Sample type
Cell line
Disease
HIV-infected disease (HID)
Quality evaluation
Normal
Reported year
2013
PubMed ID
23953889
Virus Sequence
Virus name
HIV
Reference genome
Not given
Host Sequence
Chromosome
chr6
Cytoband
p22.2
Reference genome
GRCh37/hg19
Start
26168456/26168228 (Hg38)
End
26168456/26168228 (Hg38)
Orient
+
Location type
Intronic
Fragile sites / regions
FRA6C
Target gene
HIST1H2BD
miRNAs that regulate target gene
hsa-mir-98-5p
;
hsa-mir-744-5p
;
hsa-mir-455-3p
;
hsa-mir-296-3p
;
hsa-mir-652-3p
;
hsa-mir-615-3p
;
hsa-mir-378a-3p
;
hsa-mir-3140-3p
;
hsa-mir-2054
;
hsa-mir-6780a-5p
;
hsa-mir-6779-5p
;
hsa-mir-3689c
;
hsa-mir-3689b-3p
;
hsa-mir-3689a-3p
;
hsa-mir-30b-3p
;
hsa-mir-1273h-5p
;
hsa-mir-4451
;
hsa-mir-6799-5p
;
hsa-mir-6883-5p
;
hsa-mir-6785-5p
;
hsa-mir-4728-5p
;
hsa-mir-149-3p
;
hsa-mir-7106-5p
;
hsa-mir-6086
;
hsa-mir-377-5p
;
hsa-mir-4458
;
hsa-mir-4500
;
hsa-let-7i-5p
;
hsa-let-7g-5p
;
hsa-let-7f-5p
;
hsa-let-7e-5p
;
hsa-let-7d-5p
;
hsa-let-7c-5p
;
hsa-let-7b-5p
;
hsa-let-7a-5p
;
hsa-mir-27b-5p
;
hsa-mir-3192-5p
;
hsa-mir-556-5p
;
hsa-mir-6831-5p
;
hsa-mir-3927-3p
;
hsa-mir-7851-3p
;
hsa-mir-490-3p
;
hsa-mir-6805-3p
;
hsa-mir-5691
;
hsa-mir-676-5p
;
hsa-mir-4264
;
hsa-mir-4797-3p
;
hsa-mir-622
;
hsa-mir-4698
;
hsa-mir-8063
;
hsa-mir-4282
;
hsa-mir-3978
;
hsa-mir-8078
;
hsa-mir-3935
;
hsa-mir-1287-5p
;
hsa-mir-3135b
;
hsa-mir-875-3p
;
hsa-mir-196b-5p
;
hsa-mir-196a-5p
;
hsa-mir-576-3p
;
hsa-mir-4796-3p
;
hsa-mir-93-5p
;
hsa-mir-526b-3p
;
hsa-mir-519d-3p
;
hsa-mir-20b-5p
;
hsa-mir-20a-5p
;
hsa-mir-17-5p
;
hsa-mir-106b-5p
;
hsa-mir-106a-5p
;
hsa-mir-548ah-5p
;
hsa-mir-3609
;
hsa-mir-559
;
hsa-mir-548y
;
hsa-mir-548w
;
hsa-mir-548o-5p
;
hsa-mir-548j-5p
;
hsa-mir-548i
;
hsa-mir-548h-5p
;
hsa-mir-548d-5p
;
hsa-mir-548c-5p
;
hsa-mir-548bb-5p
;
hsa-mir-548b-5p
;
hsa-mir-548ay-5p
;
hsa-mir-548au-5p
;
hsa-mir-548as-5p
;
hsa-mir-548ar-5p
;
hsa-mir-548aq-5p
;
hsa-mir-548ap-5p
;
hsa-mir-548am-5p
;
hsa-mir-548ak
;
hsa-mir-548ae-5p
;
hsa-mir-548ad-5p
;
hsa-mir-548ab
;
hsa-mir-548a-5p
;
hsa-mir-8067
;
hsa-mir-6508-5p
;
hsa-mir-670-3p
;
hsa-mir-6894-3p
;
hsa-mir-6794-3p
;
hsa-mir-7162-5p
;
hsa-mir-516b-3p
;
hsa-mir-516a-3p
;
hsa-mir-2115-5p
;
hsa-mir-4763-5p
;
hsa-mir-627-3p
;
hsa-mir-1306-3p
;
hsa-mir-4639-3p
;
hsa-mir-6780a-3p
;
hsa-mir-6852-3p
;
hsa-mir-3909
;
hsa-mir-1292-3p
;
hsa-mir-6850-3p
Nearest miRNA
hsa-mir-3691/Upstream/7596348; hsa-mir-10398/Downstream/979398;
Nearest TSS
ENST00000381078/Upstream/10082;
ENST00000614097/Downstream/3831;
Nearest CpG islands
None/Target,
chr6-CpG: 120/Upstream/11310
,
chr6-CpG: 44/Downstream/3577
Upstream sequence
CTTTCCTTTTCAATACCAAAAAAAAAAGTGTATAAAAATAAAAACTTGggccaggcccagtggctcaagcctgtaataccagcactttgggaggccaagg
Downstream sequence
cgggcagatcacctgaggtcgggagttcaagaccagcctggccaacatggagaaaccccgtctctactaaaaatacaaaattagccaggcatggtggcac
Reference
Sherrill-Mix, S., et al. HIV latency and integration site placement in five cell-based models.2013, Retrovirology 10: 90.
Sample Information
×
Sample name
Active CD4+
Sample type
Cell line
Gender
Female
CpG Island Information
×
Download
Curate